ATORVASTATIN SANDOZ atorvastatin 40 mg film-coated tablet blister pack

Země: Austrálie

Jazyk: angličtina

Zdroj: Department of Health (Therapeutic Goods Administration)

Aktivní složka:

atorvastatin calcium trihydrate, Quantity: 43.3 mg

Dostupné s:

Sandoz Pty Ltd

Léková forma:

Tablet, film coated

Složení:

Excipient Ingredients: magnesium stearate; macrogol 6000; hyprolose; titanium dioxide; lactose monohydrate; microcrystalline cellulose; polysorbate 80; croscarmellose sodium; calcium carbonate; hypromellose

Podání:

Oral

Jednotky v balení:

30

Druh předpisu:

(S4) Prescription Only Medicine

Terapeutické indikace:

Atorvastatin Sandoz is indicated as an adjunct to diet for the treatment of patients with hypercholesterolaemia. Prior to initiating therapy with atorvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemia, obstructive liver disease, other drug therapy, and alcoholism) should be identified and treated.,Atorvastatin Sandoz is indicated in hypertensive patients with multiple risk factors for coronary heart disease (CHD) which may include diabetes, history of stroke or other cerebrovascular disease, peripheral vascular disease or existing asymptomatic CHD to reduce the risk of non-fatal myocardial infarction (MI) and non-fatal stroke.,These effects do not replace the need to independently control known causes of cardiovascular (CV) mortality and morbidity such as hypertension, diabetes and smoking

Přehled produktů:

Visual Identification: White to off-white, round, biconvex film coated tablet debossed with A40 on one side, and cross scored breaking notch on the other side; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 20 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Child resistant closure

Stav Autorizace:

Registered

Datum autorizace:

2020-12-10